Perindopril erbumine and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Perindopril erbumine (perindopril erbumine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Perindopril erbumine. It is created by eHealthMe based on reports of 8,308 people who have side effects when taking Perindopril erbumine from the FDA, and is updated regularly.

What is Perindopril erbumine?

Perindopril erbumine has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 8,958 Perindopril erbumine users. Check the latest studies of Perindopril erbumine.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,656 drugs and 2,496 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

On May, 14, 2026

8,308 people reported to have side effects when taking Perindopril erbumine.
Among them, 44 people (0.53%) have Hyperglycemia.

Could Perindopril erbumine cause Hyperglycemia?

Among these 44 people:

How long have people been on Perindopril erbumine when they have Hyperglycemia? *

What is the gender of people who have Hyperglycemia when taking Perindopril erbumine? *

female: 60.98 %
male: 39.02 %

What is the age of people who have Hyperglycemia when taking Perindopril erbumine? *

What are other drugs people take besides Perindopril erbumine? *

What are other side effects people have besides Hyperglycemia? *

Diarrhea: 9 people, 20.45%
Nausea (feeling of having an urge to vomit): 8 people, 18.18%
Fatigue (feeling of tiredness): 8 people, 18.18%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 15.91%
Fever: 5 people, 11.36%
Drug Ineffective: 5 people, 11.36%
Dizziness: 5 people, 11.36%
Stress And Anxiety: 5 people, 11.36%
Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 4 people, 9.09%
Decreased Interest: 4 people, 9.09%

What are the existing conditions these people have? *

Type 2 Diabetes: 7 people, 15.91%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 6 people, 13.64%
Diabetes: 6 people, 13.64%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 9.09%
Neuroendocrine Tumor: 4 people, 9.09%
Type 1 Diabetes: 4 people, 9.09%
Sedation: 3 people, 6.82%
Diarrhea: 3 people, 6.82%
Pain: 3 people, 6.82%
Hyperthyroidism (over activity of the thyroid gland): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Perindopril erbumine and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Perindopril erbumine:

Perindopril erbumine (8,958 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Perindopril erbumine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,656 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,496 conditions)

Related publications that referenced our studies

Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on perindopril erbumine (the active ingredients of Perindopril erbumine) and Perindopril erbumine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.